Bioengineered microbiotic levodopa therapy improves cognition and reduces pathology in a rat model of Alzheimer's disease.

Abdelhamid M, Padhi P, Gifani M, Beck JS, Thomas JP, Khadse G, Kudela C, Phillips GJ, Kanthasamy AG, Counts SE

Open source

DOI
10.1111/bph.70670
Published
2026 Sep 18
Container
British journal of pharmacology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bph.70670,
  title = {Bioengineered microbiotic levodopa therapy improves cognition and reduces pathology in a rat model of Alzheimer's disease.},
  author = {Abdelhamid M and Padhi P and Gifani M and Beck JS and Thomas JP and Khadse G and Kudela C and Phillips GJ and Kanthasamy AG and Counts SE},
  year = {2026},
  journal = {British journal of pharmacology},
  doi = {10.1111/bph.70670},
  url = {https://doi.org/10.1111/bph.70670}
}

RIS

TY  - JOUR
TI  - Bioengineered microbiotic levodopa therapy improves cognition and reduces pathology in a rat model of Alzheimer's disease.
AU  - Abdelhamid M
AU  - Padhi P
AU  - Gifani M
AU  - Beck JS
AU  - Thomas JP
AU  - Khadse G
AU  - Kudela C
AU  - Phillips GJ
AU  - Kanthasamy AG
AU  - Counts SE
PY  - 2026
JO  - British journal of pharmacology
DO  - 10.1111/bph.70670
UR  - https://doi.org/10.1111/bph.70670
ER  - 

APA

M, A., P, P., M, G., JS, B., JP, T., G, K., C, K., GJ, P., AG, K., & SE, C. (2026). Bioengineered microbiotic levodopa therapy improves cognition and reduces pathology in a rat model of Alzheimer's disease.. British journal of pharmacology. https://doi.org/10.1111/bph.70670

Source records